Shattuck Labs Inc To Discuss Highlighting Data Presented at the 2021 SITC Annual Meeting Call Transcript
Good morning, everyone, and welcome to Shattuck Labs' conference call and webcast to review clinical data presented at the 36th Annual Meeting of the Society for Immunotherapy of Cancer Conference. Today's call is being recorded.
At this time, I would like to turn the call over to Conor Richardson, Senior Director of Finance and Investor Relations of Shattuck Labs. Please go ahead.
Thank you, operator. Good morning, everyone, and welcome to the Shattuck Labs conference call and webcast to discuss our first clinical data from SL-172154 and SL-279252 presented at the 36th Annual SITC conference. We will refer to these as 154 and 252 throughout today's presentation. During this morning's call, the Shattuck team will provide a clinical update for both 154 and 252 and provide context for how these distinct datasets inform the overall Agonist Redirected Checkpoint, or ARC platform, our future clinical development plans and our overall company strategy.
Before we begin, I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |